Navigation Links
Techne Corporation Announces That John L. Higgins has Accepted a Seat on Techne's Board
Date:5/19/2009

MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- Techne Corporation (Nasdaq: TECH) today announced that Mr. John L. Higgins has accepted a position on Techne's Board of Directors and will also serve as a member of Techne's Audit, Compensation and Nominations and Governance Committees. Mr. Higgins' initial term will begin immediately and run through October 29, 2009. Techne's shareholders reelect Directors on an annual basis.

Mr. Higgins has been President and Chief Executive Officer of Ligand Pharmaceuticals Incorporated since January 2007 and has been a member of Ligand's Board of Directors since March 2007. From 1997 until joining Ligand, Mr. Higgins was with Connetics Corporation, a specialty pharmaceutical company, as its Chief Financial Officer, and also served as Executive Vice President, Finance and Administration and Corporate Development at Connetics from January 2002 until its acquisition by Stiefel Laboratories, Inc. in December 2006.

Mr. Higgins was previously a member of the executive management team at BioCryst Pharmaceuticals, Inc., a biopharmaceutical company. Currently, he is a Director of BioCryst and serves as Chairperson of its Audit Committee. Before joining BioCryst in 1994, Mr. Higgins was a member of the healthcare banking team of Dillon, Read & Co. Inc., an investment banking firm. Mr. Higgins also serves as Chairman of CoMentis, Inc, a biopharmaceutical company, and has served as a director of numerous public and private companies. He graduated Magna Cum Laude with an A.B. from Colgate University.

Mr. Thomas E. Oland, Techne's Chairman and CEO, said, "I am extremely pleased with Mr. Higgins' decision to accept a position on Techne's Board. His combination of biopharmaceutical business experience and background as a chief financial officer and investment banker, combined wi
'/>"/>

SOURCE Techne Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
2. Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program
3. Techne Corporation Declares Dividend
4. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
5. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2008
6. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
7. Techne Corporation Announces Share Repurchase Authorization
8. Onyx Pharmaceuticals Files Complaint Against Bayer Corporation
9. Odyssey Thera Announces Collaboration With Mitsubishi Tanabe Pharma Corporation, and Issuance of Core Patent in Japan
10. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
11. Apex Bioventures Acquisition Corporation Receives Notice of Extension from NYSE Amex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... May 21, 2012   Cord Blood America, Inc ... CBAI ), the umbilical cord blood stem cell ... potential of stem cells to families nationwide and internationally, ... 2012 increased by 6.7%  to $1.55 million compared to ... announced a gross profit of $1.12 million in the ...
(Date:5/21/2012)... 2012  HistoRx, the leader in quantitative ... AQUA technology to assessment of messenger RNA ... and standardization of protein in tissue specimens; ... beyond protein expression analysis to quantification of ... was invented to address the challenges of ...
(Date:5/21/2012)... 21, 2012 International scientific and ... to discuss the potential use of Oxitec,s genetically modified ... combat Dengue Fever in Panama. The independent ... (STRI), The Gorgas Memorial Institute for Health Studies and ... regional experts from these institutes as well as the ...
(Date:5/21/2012)... 21, 2012  Neuralstem, Inc. (NYSE MKT: CUR) ... present at the World Stem Cells & Regenerative ... Tuesday, May 22nd at 12:30 PM. Mr. Garr,s ... review Neuralstem,s cellular therapy trial in ALS, its ... (MDD), and provide an overview on plans to ...
Breaking Biology Technology:Cord Blood America Announces First Quarter Financial Results 2Cord Blood America Announces First Quarter Financial Results 3AQUA® Technology Uses Extend Beyond Protein: Effective measurement of messenger RNA now demonstrated 2AQUA® Technology Uses Extend Beyond Protein: Effective measurement of messenger RNA now demonstrated 3Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 2Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 3Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London 2
... SAN DIEGO, May 28 Gen-Probe Incorporated,(Nasdaq: GPRO ... Europe its,APTIMA(R) HPV Assay, a highly specific molecular diagnostic ... which causes cervical,cancer. The APTIMA HPV Assay has been ... European Union countries., "The CE marking and launch ...
... AMT), a leader in the field of human gene ... Annual Meeting of,the American Society of Gene Therapy in ... its lead product AMT-011 on May 29., About ... therapy platform that to date appears to,circumvent many if ...
... Mass., May 28 Abt Associates announced that,it ... Financial Officer.,Small most recently served as Senior Vice ... Automation Inc., a $700 million,provider of factory and ... industry. Prior to joining Brooks Automation he held ...
Other Biology Technology:Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 2Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 3Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 4Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus 5AMT Announces Presentations During the 11th Annual Meeting of the ASGT 2Abt Associates Names Richard Small Vice President and Chief Financial Officer 2
(Date:5/21/2012)... A tool commonly used by financial strategists to determine ... portfolio was used to develop a diversified portfolio of ... conservation purposes given the uncertainty about climate change. , ... the history of a stock, University of Illinois environmental ... the historical climate data of the Prairie Pothole Region ...
(Date:5/21/2012)... Biomedical Research Institute (Seattle BioMed), the University of Copenhagen ... related to host-parasite interaction in severe malaria, concerning how ... the brain and cause cerebral malaria the most ... be published in the May 21 online edition of ... ), a premier scientific journal, highlighting this research. , ...
(Date:5/21/2012)... -- Chiltern International Limited (Chiltern), a global contract research ... with a CRO Leadership Award in all five ... awards are given by Life Science Leader publication ... Glenn Kerkhof , Chiltern ... as a CRO leader in the Quality, Reliability, ...
Breaking Biology News(10 mins):Financial tool considered climate change uncertainty to select land for conservation 2Financial tool considered climate change uncertainty to select land for conservation 3New discoveries about severe malaria 2Chiltern Wins CRO Leadership Award From Life Science Leader 2Arthritis in Children Linked to Infections 90594 1Arthritis in Children Linked to Infections 90594 2It takes a village to keep teens substance free 90592 1It takes a village to keep teens substance free 90592 2Bigger gorillas better at attracting mates and raising young 24768 1Bigger gorillas better at attracting mates and raising young 24768 2
... filamentous viruses make up a large fraction of known ... the viral damage to crop plants throughout the world. ... have been revealed by scientists using a variety of ... Brookhaven National Laboratory and collaborating institutions. , These findings, ...
... In pre-clinical studies, vitamin C appears to substantially reduce ... Sloan-Kettering Cancer Center. , These new findings, published in ... a publication of the American Association of Cancer Research ... but the study,s authors say the same mechanism may ...
... Women who have a history of dieting or ... an inappropriate amount of weight during pregnancy. In a ... Journal of the American Dietetic Association, researchers ... report that restrained eating behaviors prior to pregnancy were ...
Other Biology News:Structures of important plant viruses determined 2Structures of important plant viruses determined 3Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs 2Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs 3New study indicates link between weight gains during pregnancy and dieting history 2
... Maximize the value of your microarray ... offer the support you need from ... the most up to date methods. ... the Gene Expression Profiling Service or ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
... Flight Mass Analyzer for superior sensitivity, mass accuracy, and resolving power., ... * Precursor ion selection range: 150 - 4000 m/z, * Resolution: ... internal reference, * Dynamic range: 4 orders of magnitude ... ...
... pleiotropic cytokine produced by activated T cells, ... the growth of some tumour and normal ... Kaposis sarcoma cell proliferation, cytokine release from ... expression on hepatoma cells. Mouse OSM was ...
Biology Products: